| Literature DB >> 19632834 |
Chun Sing Li1, Liette Belair, Jocelyne Guay, Renata Murgasva, Wayne Sturkenboom, Yeeman K Ramtohul, Lei Zhang, Zheng Huang.
Abstract
SCD1 inhibition may represent a novel treatment for obesity, type-2 diabetes and related metabolic disorders. A prototype thiazole amide analog 13 (MF-152) was identified as an excellent tool in the study of SCD biology in animals.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19632834 DOI: 10.1016/j.bmcl.2009.07.015
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823